Effects of Interleukin-10 (IL-10) on Pain Behavior and Gene Expression Following Excitotoxic Spinal Cord Injury in the Rat

Intraspinal injection of quisqualic acid (QUIS) produces excitotoxic injury with pathophysiological characteristics similar to those associated with ischemic and traumatic spinal cord injury (SCI). Responses to QUIS-induced injury include an inflammatory component, as well as the development of spontaneous and evoked pain behaviors. We hypothesized that QUIS-induced inflammation and subsequent gene expression contribute to the development and progression of pain-related behaviors and that blockade of inflammation-related gene expression leads to the amelioration of these behaviors. Using the QUIS model of spinal cord injury, we examined whether interleukin-10 (IL-10), a potent anti-inflammatory cytokine, is able to reduce mRNA levels of inflammatory and cell death-related genes leading to a reduction of pain behaviors. The results demonstrate that animals receiving systemic injection of IL-10, 30 minutes following QUIS-induced SCI, showed a significant delay in the onset of excessive grooming behavior, a significant reduction in grooming severity, and a significant reduction in the longitudinal extent of a pattern of neuronal loss within the spinal cord characterized as "grooming-type damage." QUIS injections also resulted in an increase in mRNA levels of interleukin-1 beta (IL-1 beta), cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), CD95 ligand (CD95-L, also called FAS-L/APO-1L), and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Results of QUIS injury plus IL-10 treatment resulted in a significant downregulation of IL1-beta and iNOS mRNA and these results were supported by Western blot analysis of protein levels following IL-10 treatment. These data suggest that IL-10 reduces inflammation and that targeting injury-induced inflammation is an effective strategy for limiting the extent of neuronal damage following excitotoxic SCI and thus the onset and progression of injury-induced pain behaviors.

[1]  R. Yezierski,et al.  Cytokine involvement in dynorphin-induced allodynia , 2000, PAIN®.

[2]  T. Morrow,et al.  Chronic, Selective Forebrain Responses to Excitotoxic Dorsal Horn Injury , 2000, Experimental Neurology.

[3]  R. Yezierski,et al.  Neuroprotective Effects of Interleukin-10 Following Excitotoxic Spinal Cord Injury , 1999, Experimental Neurology.

[4]  M. C. Acosta,et al.  Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. , 1999, Journal of neurotrauma.

[5]  I. Herr,et al.  CD95 Ligand (Fas-L/APO-1L) and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Mediate Ischemia-Induced Apoptosis in Neurons , 1999, The Journal of Neuroscience.

[6]  P. Eide.  Pathophysiological mechanisms of central neuropathic pain after spinal cord injury , 1998, Spinal Cord.

[7]  B. Stokes,et al.  Cytokine mRNA Profiles in Contused Spinal Cord and Axotomized Facial Nucleus Suggest a Beneficial Role for Inflammation and Gliosis , 1998, Experimental Neurology.

[8]  R. Yezierski,et al.  Traumatic Spinal Cord Injury Induces Nuclear Factor-κB Activation , 1998, The Journal of Neuroscience.

[9]  R. Yezierski,et al.  Excitotoxic spinal cord injury: behavioral and morphological characteristics of a central pain model , 1998, Pain.

[10]  R. Myers,et al.  Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-α expression , 1998, Pain.

[11]  A. Berić.  POST-SPINAL CORD INJURY PAIN STATES , 1997 .

[12]  S. Ashley,et al.  Interleukin-10 prevents early cytokine release in severe intraabdominal infection and sepsis. , 1997, The Journal of surgical research.

[13]  J. Wrathall,et al.  Increase of interleukin-1β mRNA and protein in the spinal cord following experimental traumatic injury in the rat , 1997, Brain Research.

[14]  M. Ross,et al.  Cyclo-Oxygenase-2 Gene Expression in Neurons Contributes to Ischemic Brain Damage , 1997, The Journal of Neuroscience.

[15]  R. Yezierski.  Pain following spinal cord injury: the clinical problem and experimental studies , 1996, Pain.

[16]  C. Hulsebosch,et al.  Mechanical and thermal allodynia in chronic central pain following spinal cord injury , 1996, Pain.

[17]  R. Yezierski,et al.  Neuronal Damage following Intraspinal Injection of a Nitric Oxide Synthase Inhibitor in the Rat , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[18]  T. Olsson,et al.  Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-β , 1996, Journal of Neuroimmunology.

[19]  V. Yong,et al.  Attenuation of Astroglial Reactivity by Interleukin-10 , 1996, The Journal of Neuroscience.

[20]  K. Chung,et al.  Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages. , 1995, Journal of immunology.

[21]  L. Santambrogio,et al.  Staphylococcal enterotoxin B and tumor‐necrosis factor‐α‐induced relapses of experimental allergic encephalomyelitis: Protection by transforming growth factor‐β and interleukin‐10 , 1995, European journal of immunology.

[22]  L. Sorkin,et al.  Transient Spinal Ischemia in Rat: Characterization of Spinal Cord Blood Flow, Extracellular Amino Acid Release, and Concurrent Histopathological Damage , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  M. Schwab,et al.  Secondary Cell Death and the Inflammatory Reaction After Dorsal Hemisection of the Rat Spinal Cord , 1994, The European journal of neuroscience.

[24]  A. Blight,et al.  Effects of silica on the outcome from experimental spinal cord injury: Implication of macrophages in secondary tissue damage , 1994, Neuroscience.

[25]  K. Frei,et al.  Antigen presentation in the central nervous system. The inhibitory effect of IL-10 on MHC class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed. , 1994, Journal of immunology.

[26]  G. Gebhart,et al.  Nitric oxide (NO) and nociceptive processing in the spinal cord , 1993, Pain.

[27]  R. Yezierski,et al.  Neuronal degeneration and spinal cavitation following intraspinal injections of quisqualic acid in the rat. , 1993, Journal of neurotrauma.

[28]  A. Blight.  Macrophages and inflammatory damage in spinal cord injury. , 1992, Journal of neurotrauma.

[29]  W. Willis.  Hyperalgesia and allodynia , 1992 .

[30]  T. Mosmann,et al.  IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.

[31]  C H Tator,et al.  Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. , 1991, Journal of neurosurgery.

[32]  J. Merrill,et al.  HIV‐1, macrophages, glial cells, and cytokines in AIDS nervous system disease , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  D. McAdoo,et al.  Excitatory amino acids rise to toxic levels upon impact injury to the rat spinal cord , 1991, Brain Research.

[34]  W. Griffin,et al.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[35]  A. Faden,et al.  A potential role for excitotoxins in the pathophysiology of spinal cord injury , 1988, Annals of neurology.

[36]  Gary J. Bennett,et al.  A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man , 1988, Pain.

[37]  J. Sutherland,et al.  Electronic imaging system for direct and rapid quantitation of fluorescence from electrophoretic gels: application to ethidium bromide-stained DNA. , 1987, Analytical biochemistry.

[38]  A. Wollenberger,et al.  Determination of DNA and RNA in homogenized cells and tissues by surface fluorometry. , 1972, Analytical biochemistry.